PhD | Virginia Commonwealth University | United States
Prof. Hengbin Wang is a highly accomplished biomedical researcher specializing in epigenetics, chromatin biology, and cancer molecular mechanisms, with a strong focus on how chromatin remodeling and histone modifications regulate gene expression, genome stability, and disease progression. His research interests include Polycomb repressive complexes (PRC1), histone ubiquitination and methylation, chromatin remodelers such as RSF1, non-coding RNAs, mitochondrial regulation, and translational cancer biology, particularly in esophageal and pancreatic cancers. He possesses advanced research skills in molecular and cellular biology, epigenomic analysis, cancer genomics, functional assays, therapeutic target validation, and drug-sensitization strategies. Prof. Wang’s scientific excellence has been recognized through competitive research grants, high-impact publications, and international peer recognition, reflecting notable awards and professional honors in his field. According to Scopus, he has authored 70 documents, received 11,684 citations, and holds an h-index of 32, underscoring his significant and sustained research impact. Overall, his work bridges fundamental chromatin regulation with clinically relevant cancer therapeutics and precision medicine.
Citation Metrics (Scopus)
11684
9000
6000
3000
1000
500
100
0
View Scopus View Google Scholar View ResearchGate
Featured Publications